false
OasisLMS
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
Toggle navigation
Conferences
Conferences
World (WCLC) (36)
Asia (ACLC) (4)
Europe (ELCC) (1)
Hot Topic (4)
Latin America (LALCA) (7)
Mesothelioma (MESO) (1)
North America (NACLC) (8)
Pan-Africa (PACLC) (2)
Small Cell (SCLC) (4)
Targeted Therapies (TTLC) (11)
Cancel
Education (1)
Education
Courses (17)
Microlearning (10)
Podcasts (319)
Simulations (1)
Webinars (48)
CME (22)
Cancel
Tools/Resources
Tools/Resources
Atlases (11)
Language Guide (1)
Staging Resources (2)
Tobacco Control (104)
Cancel
Type of Thoracic Cancer
Type of Thoracic Cancer
Non-small cell lung cancer (239)
Small cell & Other Neuro-endocrine tumors (255)
Mesothelioma (80)
Thymic (43)
Cancel
Specialty/Discipline
Specialty/Discipline
Allied Health (35)
Basic Science (22)
Medical Oncology (213)
Nursing (37)
Pathology (59)
Patient Advocacy (78)
Population Health (40)
Pulmonary Medicine (50)
Radiation Oncology (81)
Radiology (23)
Statistics (18)
Thoracic Oncology (213)
Thoracic Surgery (73)
Translational Science (98)
Cancel
Publications
Publications
IASLC Lung Cancer News (ILCN) (45)
IASLC Position Statements (7)
Journal of Thoracic Oncology (JTO) (80)
JTO Clinical and Research Reports (43)
Language Guide (1)
Cancel
Search
Search Result for:
Podcasts
3
True
Courses
9
False
Content
10
False
Videos
12
False
PDFs
16
False
Others
×
Sort By
select
Price: Low to High
Price: High to Low
Highest Rating
Popularity
Most Recent
Oldest First
Alphabetical (A-Z)
Alphabetical (Z-A)
Most Relevant
Catalog Display Mode
Catalog Display Mode
Bravo! Back to Barcelona WCLC 2025 Preview Podcast
Podcast | English | 2025 | 45 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Bravo! Back to Barcelona WCLC 2025 Preview Podcast
Podcast | English | 2025 | 45 Min
No Credit
Free
From Bench to Breath: Zongertinib’s Journey Toward the First Oral HER2‑Targeted Therapy
Podcast | English | 2025 | 41 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
From Bench to Breath: Zongertinib’s Journey Toward the First Oral HER2‑Targeted Therapy
Podcast | English | 2025 | 41 Min
No Credit
Free
LCC in Arabic: Arabic Women’s Voices in Thoracic Oncology
Podcast | Arabic | 2025 | 33 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Arabic: Arabic Women’s Voices in Thoracic Oncology
Podcast | Arabic | 2025 | 33 Min
No Credit
Free
Artificial Intelligence and Lung Cancer Research
Podcast | English | 2025 | 45 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Artificial Intelligence and Lung Cancer Research
Podcast | English | 2025 | 45 Min
No Credit
Free
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
Podcast | English | 2025 | 35 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
Podcast | English | 2025 | 35 Min
No Credit
Free
“Please Don’t Tell My Family”: Stigma and Lung Cancer Podcast
Podcast | English | 2025 | 57 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
“Please Don’t Tell My Family”: Stigma and Lung Cancer Podcast
Podcast | English | 2025 | 57 Min
No Credit
Free
LCC in Japanese: ASCO 2025 Highlights Podcast
Podcast | Japanese | 2025 | 34 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Japanese: ASCO 2025 Highlights Podcast
Podcast | Japanese | 2025 | 34 Min
No Credit
Free
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
Podcast | English | 2025 | 22 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
Podcast | English | 2025 | 22 Min
No Credit
Free
Data Dive: Unpacking Datopotomab Deruxtecan and Its Recent FDA Approval
Podcast | English | 2025 | 45 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Data Dive: Unpacking Datopotomab Deruxtecan and Its Recent FDA Approval
Podcast | English | 2025 | 45 Min
No Credit
Free
FDA Approval: Sunvozertinib in EGFR Exon 20 NSCLC
Podcast | English | 2025 | 41 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
FDA Approval: Sunvozertinib in EGFR Exon 20 NSCLC
Podcast | English | 2025 | 41 Min
No Credit
Free
LCC in Portuguese: Virtual Tumor Board – EGFR NSCLC
Podcast | Portuguese | 2025 | 46 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Portuguese: Virtual Tumor Board – EGFR NSCLC
Podcast | Portuguese | 2025 | 46 Min
No Credit
Free
Virtual Tumor Board: Resectable EGFR NSCLC
Podcast | English | 2025 | 39 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Virtual Tumor Board: Resectable EGFR NSCLC
Podcast | English | 2025 | 39 Min
No Credit
Free
FDA Approval: Taletrectinib and ROS1 NSCLC
Podcast | English | 2025 | 29 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
FDA Approval: Taletrectinib and ROS1 NSCLC
Podcast | English | 2025 | 29 Min
No Credit
Free
Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
Podcast | English | 2025 | 45 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
Podcast | English | 2025 | 45 Min
No Credit
Free
ASCO 2025 Highlights
Podcast | English | 2025 | 55 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
ASCO 2025 Highlights
Podcast | English | 2025 | 55 Min
No Credit
Free
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC Podcast
Podcast | English | 2025 | 33 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC Podcast
Podcast | English | 2025 | 33 Min
No Credit
Free
LCC in Korean: Lung Cancer Updates & Future Directions Podcast
Podcast | Korean | 2025 | 33 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Korean: Lung Cancer Updates & Future Directions Podcast
Podcast | Korean | 2025 | 33 Min
No Credit
Free
Global Advances and Persistent Disparities in Lung Cancer Treatment Podcast
Podcast | English | 2025 | 47 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Global Advances and Persistent Disparities in Lung Cancer Treatment Podcast
Podcast | English | 2025 | 47 Min
No Credit
Free
Virtual Tumor Board: Targeting Residual Disease Podcast
Podcast | English | 2025 | 49 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Virtual Tumor Board: Targeting Residual Disease Podcast
Podcast | English | 2025 | 49 Min
No Credit
Free
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC Podcast
Podcast | Mandarin Chinese | 2025 | 28 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC Podcast
Podcast | Mandarin Chinese | 2025 | 28 Min
No Credit
Free
Course
1
to
20
of
319
×
Please select your language
1
English